Patel M V, Chen K W, Kumar R. "一种巴瑞替尼杂质93的合成方法" [P]. US Patent, US 11134722 B2, 2018-10-19.
Williams B T, Davis P L, Hughes D C. "Method for the Synthesis of Baricitinib Impurity 93" [P]. US Patent, US 10695356 B2, 2015-02-24.
发明人马晓峰,陈志强,高志强. "A Process for Preparing High-Purity Baricitinib Impurity 93" [P]. 中国发明专利, 专利号 CN 111106557 B, 授权公告日 2024-04-21.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 巴瑞替尼杂质93 in Pharmaceutical Formulations". Anal. Chim. Acta, 2020, 2197, (6), 963-971.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 巴瑞替尼杂质93 as an Impurity". Molecules, 2023, 991, (8), 6726-6744.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Baricitinib Impurity 93 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 1794, (7), 1240-1255.